09/08/2025 09:00
IFF expands LMR Naturals site in Grasse, advancing naturals innovation leadership

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences, today inaugurated its expanded LMR Naturals site in Grasse following a €10 million investment. The expansion increases the facility’s footprint by 75 percent to 4,687 square meters and includes a state-of-the-art pilot hall designed to accelerate the development of new natural ingredients. The upgraded site also counts on a newly completed experimental field nearby that will provide direct access to plant...

09/08/2025 09:25
Hopae and INCERT Partner to Make Hopae Connect the First EU-Registered Intermediary for a wide adoption and use of EU Digital Identity Wallet

Hopae Inc., creator of the Hopae Connect – Global eID and Wallet orchestration platform, and INCERT GIE, Luxembourg’s public trust infrastructure agency, today announced a strategic partnership to make Hopae Connect the first officially registered Intermediary Service in the EU under the eIDAS 2.0 regulation. — eIDAS 2.0 is the EU regulation that aims to deliver to every European a government-backed Digital Identity Wallet by the end of 2026—and makes it mandatory for banks, airlines, telec...

09/12/2025 20:05
SUI Group Announces Completion of Existing $2 Million Stock Repurchase Program and Subsequent Authorization of New $50 Million Program

SUI Group Holdings Limited (“SUI Group,” “SUIG” or the “Company”) (NASDAQ: SUIG), the only publicly traded company with an official relationship with the Sui Foundation, today announced it has completed its previously authorized $2 million stock repurchase program. SUI Group is also announcing that its Board of Directors has now authorized a new stock repurchase program to acquire up to an additional $50 million of the Company’s common stock. Following the completion of its initial stock repu...

09/08/2025 11:00
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotechnology company pioneering human-first antibody discovery and design, announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program. The first antibody in Infinimmune’s therapeutic drug development pipeline, IFX-101, targets atopic dermatitis and is designed to deliver superior effica...

09/08/2025 11:00
Deep Fission Nuclear Completes $30M Financing in a Go-Public Transaction

Deep Fission, Inc. (“Deep Fission” or the “Company”), a pioneering advanced nuclear energy company placing small modular pressurized water reactors in boreholes one mile underground, announced today it raised $30M in a heavily oversubscribed private placement offering at $3.00 per share as well as completed a go-public reverse merger transaction with Surfside Acquisition Inc., which has been renamed Deep Fission, Inc. The Department of Energy (DOE) recently announced that Deep Fission was sel...

09/08/2025 11:00
AEM Acquires Van Essen Instruments, Integrating Advanced Water-Level Monitoring Across Global Environmental Resiliency Capabilities

AEM (aem.eco), the essential source for environmental insights, today announced the acquisition of Van Essen Instruments, a renowned provider of precision groundwater and surface water monitoring systems. Through this acquisition, AEM integrates Van Essen’s rugged sensor hardware, telemetry solutions, and robust data management tools into the AEM Elements® environmental resiliency platform, delivering a unified solution for monitoring water, weather, and other environmental risks. For more th...